(Q90082642)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

title

Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

1 reference

13

William R Schief

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

9

Elise Landais

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

author name string

Mariane Melo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Ely Porter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Yuan Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Murillo Silva

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Na Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Brian Dobosh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Alessia Liguori

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Pat Skog

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Sergey Menis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Devin Sok

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

David Nemazee

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Ron Weiss

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Darrell J Irvine

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

publication date

19 August 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

page(s)

2080-2090

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic.

11 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Developing an HIV vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

The quest for an antibody-based HIV vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Germline-targeting immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Prime-boost vaccine strategy against viral infections: Mechanisms and benefits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Molecular mechanisms for enhanced DNA vaccine immunogenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Modified mRNA Vaccines Protect against Zika Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Self-replicating alphavirus RNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Nonviral delivery of self-amplifying RNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Sindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Immunology: Fifty years of B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Antibody responses to envelope glycoproteins in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Messenger RNA-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Vaccines 'on demand': science fiction or a future reality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Germinal center enhancement by extended antigen availability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Enhancement of antitumor immunity using a DNA-based replicon vaccine derived from Semliki Forest virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2019.08.007

10.1016/J.YMTHE.2019.08.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31515132%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

1 reference